TEXT OF STORY
SCOTT JAGOW: Smokers wanting to quit? Here’s something else to try: a new pill from Pfizer, called Varenicline.
Today, the Journal of the American Medical Association releases three studies about it. Now, the studies were paid for by Pfizer, but they do suggest it’s easiest to quit smoking after taking this pill for a year.
Analyst Les Funtleyder says considering how many people fail to quit smoking, Pfizer could have a $400 million drug here.
LES FUNTLEYDER: “In general that’s not considered a blockbuster, but it’s a nice size drug, and given that Pfizer needs to replace numerous products that are going off patent in its pipeline, it’ll be helpful.”
The FDA has already approved Varenicline.
A lot of smokers buy whitening toothpaste I’m sure. Might want to check out the latest Consumer Reports. They tested 41 brands of toothpaste and found no real link between claims of whitening and actual stain-removing.
Only one brand stood out as a stain-remover: Ultrabrite All-in-One Advanced Whitening.
Marketplace is on a mission.
We believe Main Street matters as much as Wall Street, economic news is made relevant and real through human stories, and a touch of humor helps enliven topics you might typically find…well, dull.
Through the signature style that only Marketplace can deliver, we’re on a mission to raise the economic intelligence of the country—but we don’t do it alone. We count on listeners and readers like you to keep this public service free and accessible to all. Will you become a partner in our mission today?